Compagnie Lombard Odier SCmA’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,000
| Closed | -$144K | – | 441 |
|
|
2025
Q3 | $144K | Buy |
+1,000
| New | +$137K | ﹤0.01% | 274 |
|
|
2025
Q2 | – | Sell |
-1,800
| Closed | -$230K | – | 479 |
|
|
2025
Q1 | $230K | Hold |
1,800
| – | – | ﹤0.01% | 250 |
|
|
2024
Q4 | $238K | Hold |
1,800
| – | – | ﹤0.01% | 227 |
|
|
2024
Q3 | $262K | Hold |
1,800
| – | – | ﹤0.01% | 216 |
|
|
2024
Q2 | $247K | Hold |
1,800
| – | – | ﹤0.01% | 223 |
|
|
2024
Q1 | $247K | Sell |
1,800
-2,550
| -59% | -$348K | ﹤0.01% | 238 |
|
|
2023
Q4 | $591K | Buy |
+4,350
| New | +$531K | 0.01% | 206 |
|
|
2023
Q1 | – | Sell |
-500
| Closed | -$66K | – | 651 |
|
|
2022
Q4 | $66K | Hold |
500
| – | – | ﹤0.01% | 442 |
|
|
2022
Q3 | $58K | Buy |
+500
| New | +$62.1K | ﹤0.01% | 448 |
|
|
2022
Q1 | – | Sell |
-300
| Closed | -$46K | – | 636 |
|
|
2021
Q4 | $46K | Buy |
+300
| New | +$46.4K | ﹤0.01% | 515 |
|
|
2021
Q2 | – | Sell |
-150
| Closed | -$23K | – | 652 |
|
|
2021
Q1 | $23K | Hold |
150
| – | – | ﹤0.01% | 563 |
|
|
2020
Q4 | $23K | Buy |
+150
| New | +$21.4K | ﹤0.01% | 495 |
|
|
2019
Q2 | – | Sell |
-900
| Closed | -$101K | – | 561 |
|
|
2019
Q1 | $101K | Buy |
+900
| New | +$98.7K | ﹤0.01% | 350 |
|
|
2017
Q4 | – | Sell |
-900
| Closed | -$100K | – | 669 |
|
|
2017
Q3 | $100K | Buy |
+900
| New | +$96.2K | ﹤0.01% | 439 |
|
|
2017
Q2 | – | Sell |
-315
| Closed | -$31K | – | 727 |
|
|
2017
Q1 | $31K | Sell |
315
-480
| -60% | -$46K | ﹤0.01% | 588 |
|
|
2016
Q4 | $70K | Buy |
795
+315
| +66% | +$28.7K | ﹤0.01% | 568 |
|
|
2016
Q3 | $46K | Hold |
480
| – | – | ﹤0.01% | 688 |
|
|
2016
Q2 | $41K | Hold |
480
| – | – | ﹤0.01% | 692 |
|
|
2016
Q1 | $42K | Hold |
480
| – | – | ﹤0.01% | 740 |
|
|
2015
Q4 | $54K | Hold |
480
| – | – | ﹤0.01% | 680 |
|
|
2015
Q3 | $49K | Hold |
480
| – | – | ﹤0.01% | 609 |
|
|
2015
Q2 | $59K | Sell |
480
-5,325
| -92% | -$637K | ﹤0.01% | 623 |
|
|
2015
Q1 | $665K | Buy |
+5,805
| New | +$640K | 0.03% | 274 |
|
|
2014
Q4 | – | Sell |
-2,250
| Closed | -$205K | – | 808 |
|
|
2014
Q3 | $205K | Hold |
2,250
| – | – | 0.01% | 498 |
|
|
2014
Q2 | $193K | Hold |
2,250
| – | – | 0.01% | 532 |
|
|
2014
Q1 | $177K | Buy |
+2,250
| New | +$187K | 0.01% | 546 |
|
Other funds holding IBB
Compagnie Lombard Odier SCmA's IBB Position: Q4 2025 in Review
Compagnie Lombard Odier SCmA sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 1,000 shares — an estimated $144K sold.
Compagnie Lombard Odier SCmA first reported a position in IBB in Q1 2014 and held it in 26 quarters. The position peaked at $665K in Q1 2015. 959 funds tracked by Wall St. Rank hold IBB as of Q4 2025.
- Compagnie Lombard Odier SCmA reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
- Compagnie Lombard Odier SCmA sold 1,000 iShares Biotechnology ETF shares in Q4 2025, an estimated $144K.
- Compagnie Lombard Odier SCmA first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 26 quarters.
- Compagnie Lombard Odier SCmA's iShares Biotechnology ETF position peaked at $665K in Q1 2015.
- 959 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2025, filed 16 Jan 2026.